FDA Inspection
Grifols Biologicals LLCGrifols Biologicals LLC – FDA Inspection, Sep 12, 2019
Record Details
This FDA Inspection record concerns Grifols Biologicals LLC, with an inspection on September 12, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Decarlos A. Gomez (Issuing Officer)
- Malgorzata G. Norton (Company Rep)
- Nobuko H. Katagiri (Issuing Officer)
- Olga Simakova (Issuing Officer)
- Omotunde O. Osunsanmi (Issuing Officer)
- Vijaya L. Simhadri (Issuing Officer)
View Company Profile
ID · 14818d46-7a63-4b36-8d06-50d56c6e46cd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1105923
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Biologicals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 17, 2026 | Not classified | Los Angeles District Office | Blood and Blood Products |
| May 3, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2019 | Not classified | Los Angeles District Office | |
| August 24, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 20, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Biologicals LLC
- FDA Inspection 1336990 - 2026-09-17
- FDA Inspection 1229139 - 2024-05-03
- FDA Inspection 1088286 - 2019-01-31
- FDA Inspection 1027351 - 2017-08-24
- FDA Inspection 944819 - 2015-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.